13 Recruiting Studies Using Zanidatamab
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Zanidatamab
A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers
📍 Hospital de Gastroenterología Dr Bonorino Udaondo — Buenos Aires,
Gastric Neoplasms
View Study & Checklist ➔Zanidatamab Outcomes and Lived Experiences in Advanced HER2+ GEA
📍 UCI Health - Chao Family Comprehensive Cancer Center — Orange, California
Esophageal Cancer
View Study & Checklist ➔AACR Adaptive Biomarker-Driven Organ Preservation Trial in Gastroesophageal Adenocarcinomas
📍 University of California, Los Angeles — Los Angeles, California
Gastroesophageal Adenocarcinoma
View Study & Checklist ➔PRE-I-SPY Phase I/Ib Oncology Platform Program
📍 The University of Alabama at Birmingham O'Neal Comprehensive Cancer Center — Birmingham, Alabama
HER2-positive Breast Cancer
View Study & Checklist ➔I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
📍 University of Alabama at Birmingham — Birmingham, Alabama
Breast Neoplasms
View Study & Checklist ➔Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
📍 The Oncology Institute of Hope and Innovation — Cerritos, California
Metastatic Breast Cancer
View Study & Checklist ➔A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
📍 Arizona Oncology Associates, PC - NAHOA — Prescott, Arizona
Breast Cancer
View Study & Checklist ➔A Phase 2 Single-Arm Open-Label Pilot Trial Evaluating Zanidatamab (ZW25) in Patients With Early Stage HER2/Neu Positive (HER2+) Breast Cancer (BC)
📍 M D Anderson Cancer Center — Houston, Texas
Breast Cancer
View Study & Checklist ➔Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
📍 City of Hope(City of Hope National Medical Center, City of Hope Medical Center) — Duarte, California
Biliary Tract Cancer
View Study & Checklist ➔Paclitaxel and Ramucirumab +/- Zanidatamab in HER2 Postive Advanced Gastroesophageal Adenocarcinoma
📍 Arthur J.E. Child Comprehensive Cancer Centre — Calgary, Alberta
Gastroesophageal Adenocarcinoma
View Study & Checklist ➔A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer
📍 Mayo Clinic Scottsdale - PPDS — Phoenix, Arizona
Metastatic HER2-positive Breast Cancer
View Study & Checklist ➔Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment
📍 Emory University Hospital Midtown — Atlanta, Georgia
Colon Carcinoma
View Study & Checklist ➔A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
📍 Oncology Institute — Long Beach, California
HER2-positive Breast Cancer
View Study & Checklist ➔